Dr. Kamal Haider, MD

Dr. Haider practices at Lakeland Regional Health Systems, Inc. in Lakeland, Florida.

Dr. Haider's NPI, 1659376192, was assigned on June 20, 2005. Dr. Haider graduated from King Edward Medical University in 1981. Dr. Haider holds Florida license ME65316.

Dr. Haider's primary practice is Lakeland Regional Health Systems, Inc., at 3525 Lakeland Hills Blvd, Lakeland, FL 33805 in Polk County. The practice phone is (863) 687-7251.

Dr. Haider's primary practice is Lakeland Regional Health Systems, Inc. in Lakeland, Florida. Dr. Haider is also affiliated with Lakeland Regional Health Medical Center. The medical group on file is Lakeland Regional Health. Dmand AI also links Dr. Haider to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Haider practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Haider's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Haider is board certified in hematology by the American Board of Internal Medicine. Dr. Haider is licensed in Florida.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances, lung cancer and lymphedema among the conditions Dr. Haider treats.

CMS data shows 3,221 Medicare services from Dr. Haider across 23 procedure codes in 2024, for 265 Medicare patients. Medicare paid $105,769 for them.

CMS counts 265 Medicare patients who saw Dr. Haider in 2024. The largest group is 65 to 74, with 106 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Haider's median patient age at 71, with 56% women.

In 2024, Dr. Haider wrote 2,086 Medicare Part D claims for 346 patients. 75% of them were for generic drugs. CMS names the drug for 1,769 of them, across 46 drugs with 11 or more claims each, at $5,936,255 in total drug cost. In 2023, CMS named 1,560 claims across 39 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Haider for performance year 2024, reported as part of a group. Dr. Haider accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Haider as offering telehealth.

Dmand AI links 23 papers to Dr. Haider, published from 2013 to 2025. 2021 was the busiest year, with 3. The most frequent topics are Saskatchewan, Antineoplastic Combined Chemotherapy Protocols and Chemotherapy, Adjuvant. Dr. Haider has published most often in Cancers (Basel). Dr. Haider's most frequent co-authors are Donald Nelson Gardner, MD and Jong Min Rho, MD.

Dmand AI links Dr. Haider to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Fatigue and Colonic Neoplasms.

CMS Open Payments shows 60 general payments to Dr. Haider from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 50% of the total. Puma Biotechnology, Inc. paid the most, $1,151.

Dmand AI lists 1 award for Dr. Haider, most recently CMS Stage 1 2012 in 2011.

Dr. Haider graduated from King Edward Medical University in 1981. Dr. Haider is a member of ASCO.

Dr. Haider is in network with 15 carriers, including Excellus BlueCross BlueShield, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.